Skip to main content

Lion s Revenues Tank, Losses Narrow in Q4 of FY2003/2004

NEW YORK, May 4 (GenomeWeb News) - Lion Bioscience revenues took a nosedive, while its losses narrowed during its fourth quarter of fiscal year 2003/2004, which ended March 31. The company reported preliminary results for the quarter today.

 

Lion's revenues plummeted to €3.1 million ($3.7 million), from €9 million ($10.9 million) during the same quarter a year ago.

 

The company's net loss totaled €4.9 million, down from €18.5 million during the same period last year.

 

As of March 31, Lion had €43.1 million in cash and cash equivalents.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.